ATNM
Price
$1.48
Change
+$0.05 (+3.50%)
Updated
May 9 closing price
Capitalization
46.17M
2 days until earnings call
COEP
Price
$9.50
Change
+$0.74 (+8.45%)
Updated
May 9 closing price
Capitalization
31.97M
Ad is loading...

ATNM vs COEP

Header iconATNM vs COEP Comparison
Open Charts ATNM vs COEPBanner chart's image
Actinium Pharmaceuticals
Price$1.48
Change+$0.05 (+3.50%)
Volume$176.77K
Capitalization46.17M
Coeptis Therapeutics Holdings
Price$9.50
Change+$0.74 (+8.45%)
Volume$94.63K
Capitalization31.97M
ATNM vs COEP Comparison Chart
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. COEP commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and COEP is a Hold.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (ATNM: $1.48 vs. COEP: $9.50)
Brand notoriety: ATNM and COEP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 22% vs. COEP: 141%
Market capitalization -- ATNM: $46.17M vs. COEP: $31.97M
ATNM [@Biotechnology] is valued at $46.17M. COEP’s [@Biotechnology] market capitalization is $31.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileCOEP’s FA Score has 0 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • COEP’s FA Score: 0 green, 5 red.
According to our system of comparison, COEP is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 6 TA indicator(s) are bullish while COEP’s TA Score has 3 bullish TA indicator(s).

  • ATNM’s TA Score: 6 bullish, 3 bearish.
  • COEP’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ATNM is a better buy in the short-term than COEP.

Price Growth

ATNM (@Biotechnology) experienced а -4.52% price change this week, while COEP (@Biotechnology) price change was +16.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

ATNM is expected to report earnings on Jul 28, 2025.

COEP is expected to report earnings on Apr 02, 2025.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATNM($46.2M) has a higher market cap than COEP($32M). COEP YTD gains are higher at: 72.727 vs. ATNM (17.460). ATNM has more cash in the bank: 78.7M vs. COEP (1.14M). ATNM (1.71M) and COEP (1.78M) have identical debt.
ATNMCOEPATNM / COEP
Capitalization46.2M32M144%
EBITDA-44.15MN/A-
Gain YTD17.46072.72724%
P/E RatioN/AN/A-
Revenue81KN/A-
Total Cash78.7M1.14M6,922%
Total Debt1.71M1.78M96%
FUNDAMENTALS RATINGS
ATNM vs COEP: Fundamental Ratings
ATNM
COEP
OUTLOOK RATING
1..100
862
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
5642
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COEP's Valuation (57) in the null industry is in the same range as ATNM (75) in the Biotechnology industry. This means that COEP’s stock grew similarly to ATNM’s over the last 12 months.

COEP's Profit vs Risk Rating (94) in the null industry is in the same range as ATNM (100) in the Biotechnology industry. This means that COEP’s stock grew similarly to ATNM’s over the last 12 months.

ATNM's SMR Rating (98) in the Biotechnology industry is in the same range as COEP (100) in the null industry. This means that ATNM’s stock grew similarly to COEP’s over the last 12 months.

COEP's Price Growth Rating (42) in the null industry is in the same range as ATNM (56) in the Biotechnology industry. This means that COEP’s stock grew similarly to ATNM’s over the last 12 months.

COEP's P/E Growth Rating (100) in the null industry is in the same range as ATNM (100) in the Biotechnology industry. This means that COEP’s stock grew similarly to ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNMCOEP
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
49%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
52%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
52%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
48%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
47%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
40%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
61%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 6 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
48%
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 2 days ago
21%
View a ticker or compare two or three
Ad is loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF
BTC.X102970.850000-270.609380
-0.26%
Bitcoin cryptocurrency

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with GBIO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
+3.50%
GBIO - ATNM
46%
Loosely correlated
+0.06%
AURA - ATNM
36%
Loosely correlated
-9.83%
IMNM - ATNM
34%
Loosely correlated
-3.24%
PRLD - ATNM
34%
Loosely correlated
-4.49%
ABCL - ATNM
33%
Loosely correlated
+1.00%
More

COEP and

Correlation & Price change

A.I.dvisor indicates that over the last year, COEP has been loosely correlated with TVRD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if COEP jumps, then TVRD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COEP
1D Price
Change %
COEP100%
+8.45%
TVRD - COEP
36%
Loosely correlated
-1.69%
QRON - COEP
36%
Loosely correlated
N/A
APLT - COEP
26%
Poorly correlated
-2.44%
PDSB - COEP
25%
Poorly correlated
-1.64%
ATNM - COEP
24%
Poorly correlated
+3.50%
More